Scripta Insights

Scripta Insights is a healthcare technology company that focuses on pharmacy benefits management. Its approach combines technology with an understanding of pharmacy benefit management to offer a solution aimed at reducing costs and improving medication access for patients.

The company's platform, powered by its Med Mapper AI software, provides patients with insight to choose the right medications at the best prices, aiming for healthier outcomes through informed prescription decisions. This platform has mapped over 15,000 medications and medical devices to identify savings opportunities across various categories, including generics, brands, specialty drugs, over-the-counter medications, and medical supplies. It covers all drug forms, from injectables to infusions, providing comprehensive options for savings. Through this platform, members and plan sponsors can identify possible savings avenues, from therapeutic alternatives to coupons, making the process of finding cost-effective medication straightforward and customizable to individual needs.

The company also offers an app that empowers patients with the information and tools necessary to make informed choices about their prescriptions in consultation with their healthcare providers.

In May 2024, the company appointed David Kershaw as its new chief technology officer (CTO). In his new role at Scripta, Kershaw began overseeing the company's technological direction and innovation and lead the engineering and IT teams in creating solutions that include Scripta's Med Mapper and member app.

Key customers and partnerships

Scripta Insights collaborates with self-insured employers and health plan providers, offering solutions to help members find the most affordable options for their medications. The company's client list includes notable organizations such as Graham, Healthfirst, Shields Health Care Group, Cubic Corporation, and NOV.

In August 2023, Scripta Insights partnered with Mark Cuban Cost Plus Drug Company to make prescription medicines more affordable and accessible. The collaboration between the companies was expected to integrate Cost Plus Drugs' discounted pricing into Scripta's Med Mapper, thereby enhancing its range of saving strategies. This mutual intent to provide the lowest possible price for prescription medications would assist in reducing the out-of-pocket costs for consumers.